Nationwide Fund Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,300
Closed -$23K 163
2017
Q3
$23K Hold
5,300
﹤0.01% 3101
2017
Q2
$24K Hold
5,300
﹤0.01% 3099
2017
Q1
$22K Hold
5,300
﹤0.01% 3078
2016
Q4
$22K Sell
5,300
-4,400
-45% -$21.4K ﹤0.01% 3081
2016
Q3
$58K Hold
9,700
﹤0.01% 3025
2016
Q2
$48K Hold
9,700
﹤0.01% 3081
2016
Q1
$44K Buy
+9,700
New +$44K ﹤0.01% 3008
2015
Q2
Sell
-4,011
Closed -$29K 3311
2015
Q1
$29K Buy
4,011
+17
+0.4% +$129 ﹤0.01% 3156
2014
Q4
$32K Buy
3,994
+2,517
+170% +$21.4K ﹤0.01% 3060
2014
Q3
$15K Buy
+1,477
New +$15K ﹤0.01% 3193

Other funds holding ASPN

Nationwide Fund Advisors's ASPN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Aspen Aerogels (ASPN) in Q4 2017, closing a stake of 5,300 shares — an estimated $23K sold.

Nationwide Fund Advisors first reported a position in ASPN in Q3 2014 and held it in 10 quarters. The position peaked at $58K in Q3 2016. 48 funds tracked by Wall St. Rank hold ASPN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Aspen Aerogels position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 5,300 Aspen Aerogels shares in Q4 2017, an estimated $23K.
  • Nationwide Fund Advisors first reported a position in Aspen Aerogels in Q3 2014 and held it in 10 quarters.
  • Nationwide Fund Advisors's Aspen Aerogels position peaked at $58K in Q3 2016.
  • 48 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.